Table 2.

Commonly used radiopharmaceuticals for targeted radionuclide therapy (Ersahin et al., 2011)

Radiopharmaceutical	Targeting mechanism	Indication
131I-iodide	Thyroid hormone synthesis	Differentiated thyroid cancer, Graves’ disease, hyperfunctioning nodules
90Y-microspheres	Intravascular trapping	Liver metastasis, hepatocellular carcinoma
89Sr-chloride	Calcium analogue	Bone pain palliation
153Sm-EDTMP	Chemo-adsorption	Bone pain palliation
90Y-octreotide	Somatostatin receptor binding	Neuroendocrine tumours
131I-MIBG	Active transport into neuroendocrine cells and intracellular storage	Neuroblastoma, pheochromacytoma, carcinoid, paraganglioma, medullary thyroid carcinoma